The Texas Medical Center, the largest medical complex in the world, today announced the TMC Venture Fund, a $25 million initiative designed to support technologies and early-stage companies to flourish in Houston’s health care ecosystem and further the TMC’s mission to advance health, education and research.
The Texas Medical Center unveiled plans for the TMC Venture Fund to an audience of more than 600 investors, hospital stakeholders, advisors and members of Houston’s innovation ecosystem who are gathered for TMCx Demo Day.
“The TMC Venture Fund is a quintessential example of the Texas Medical Center’s ongoing commitment to driving collaboration across our medical city and further establishing Texas as the third coast of life sciences in the United States,” said Bill McKeon, Texas Medical Center President and Chief Executive Officer.
The TMC Venture Fund Board of Directors includes members of the TMC Board and management. Companies interested in applying for funding will find an application on the TMC Venture Fund website. Recipients will be selected by a TMC Venture Fund Investment Committee, whose members all share expertise, passion and experience in shepherding early-stage technology companies into next-generation services and products.
The TMC Venture Fund Investment Committee is comprised of Chair Bill McKeon, Texas Medical Center President and CEO; Barbara Bass, M.D., Houston Methodist Hospital; Juliana Garaizar, Houston Angel Network; Erik Halvorsen, Ph.D., TMC Innovation Institute; Bernard A. Harris, Jr., M.D., Vesalius Ventures; Chester J. Koh, M.D., Texas Children’s Hospital; Adam Kuspa, Ph.D., Baylor College of Medicine; Larry Lawson, GOOSE Society; Tom Luby, Ph.D., JLABS @ TMC; and Ferran Prat, Ph.D., J.D., MD Anderson Cancer Center.
The TMC Venture Fund will help accomplish one of the key tenets of the Texas Medical Center Strategic Plan by transforming innovative ideas into tangible solutions for improving heath. The fund will provide monetary resources to young startups in the health care space with a nexus to Houston and the Texas Medical Center. These early, but critical-stage, investments heighten companies’ chances of receiving additional funding and long-term success.
“I am delighted that the Texas Medical Center continues to execute on a strategic plan that represents the shared vision of our board of directors and the leadership of our member institutions,” noted Texas Medical Center Chairman O. Holcombe Crosswell. “We want this fund to give young companies the resources they need to grow the health care ecosystem in Houston and, ultimately, advance patient care.”
The TMC Venture Fund Investment Committee has selected the following 2017 recipients:
- ALLEVIANT: Alleviant Medical is focused on developing a novel minimally-invasive device to treat congestive heart failure. Their proprietary technology is designed to relieve heart failure symptoms, improve quality of life and reduce hospital admissions for more than 16 million patients currently suffering from this disease in the U.S. and abroad.
- BRITESEED: Briteseed is commercializing a new class of smart surgical tools that have artificial-vision assistance to help surgeons quickly identify landmarks and safely navigate vital structures. These multifunctional tools have the benefit of cautery, dissection and optical tissue sensing in a single package.
- CNSDOSE: CNSDose uses advanced genetic technology to fast-track finding the right antidepressant and dose. Genetically guided prescribing via CNSDose results in a 2.5 times greater likelihood of remission, which means faster recovery, reducing suffering and cutting costs that result from trial-and-error prescribing.
- MEDABLE: Medable is transforming health care by providing an enterprise platform for “Direct-to-Patient” clinical care and clinical trials, enabling patient-generated data to drive health care delivery, research and personalized and predictive medicine.
- NONINVASIX: To reduce the incidence of neonatal mortality and morbidity, Noninvasix is developing a patient monitor to directly, accurately and noninvasively measure brain oxygenation in premature babies in the neonatal intensive care unit. Real-time brain oxygenation monitoring will allow doctors to intervene before neurological function is permanently compromised.
“The TMC Venture Fund is another step forward in TMC’s creation and cultivation of a life sciences hub that will be based in Houston, the most diverse city in the nation,” McKeon concluded.
How Richard Manning enjoys life during #colorectalcancer treatment: https://t.co/ED3Lgo0qVI #CancerMoonshot #crcmsm #endcancer https://t.co/m9DJDHEzck
The three focus areas of our Prostate #CancerMoonshot: - overcoming treatment resistance - exploring #immunotherapy - understanding the tumor environment Learn more: https://t.co/0ZQCm8tMdR #PCSM #endcancer
The @GlasscockSchool's fall course catalog is chock-full of offerings for ever-curious learners, including classes in the humanities and sciences, foreign languages and personal and professional development. https://t.co/A793BrcLfz https://t.co/8a1K8LbHE2
Last Shasta County Navy Veteran who survived Pearl Harbor attack laid to rest https://t.co/lc5ODzbk9l via @JimSchultz_RS
One internal medicine resident looks back at a time where a patient helped him realize the balance of overly identifying with patients and complete detachment. https://t.co/7xsFWEhVc4
Santa Clarita Air Force Veteran Launches Campaign For Web Series To Depict Modern Soldier Life https://t.co/Td0ds3jxue via @KHTSRADIO
Today’s #VeteranOfTheDay is @USArmy Veteran Stanley Nelson. https://t.co/SHml8yEysj
U.S. Department of Veterans AffairsVeteransAffairs
Today’s #VeteranOfTheDay is Army Veteran Stanley Nelson. Stanley served from 1949 to 1952.Stanley, from Otwell, Indiana in Pike County, joined the Army in 1949 and completed training at Fort Knox. He was sent to Japan and in 1950 was assigned to the 8th Engineer Combat Battalion, 1st Calvary in Korea during the Korean War. On February 14, 1951, Stanley was defending the flank of advancing soldiers near Chipyong in modern-day South Korea. He was wounded by small arms fire in the right shoulder, right foot, left leg and left foot. Stanley was left incapacitated and was captured by the enemy.Stanley endured torture and difficult conditions while held prisoner and was left to die. However, American forces discovered him and evacuated him for medical treatment. The lower part of Stanley’s leg was amputated the following month and he recovered at Percy James Army Hospital in Battle Creek, Michigan. He was medically retired on January 31, 1952.Thank you for your service, Stanley!
Thank you @MBThewoodlands for supporting student scholarships at @MDA_UTHGrad! It also is hosting our next House Calls web chat on sports medicine this Thursday, July 19, at 6:30 p.m. CST at https://t.co/N5UU1Jx4pq. Submit a question for our experts by using #UTHealthHouseCalls.
RT @abc13houston: The most common sports injuries are strains and sprains, but do you know when you might need to see a doctor? The experts…
RT @BCMHouston_News: Tune in to @FOX26Houston tomorrow in the 8 am hour to hear @bcmhouston's Dr. El-Serag discuss the recent CDC report on…
#Cancerpain can be related to the disease and treatment. Hear from Dr. Salahadin Abdi on how patients can find relief. #endcancer https://t.co/snFVjDUjNe
RT @HealthyWomen: 10 Sneaky Ways to Get Fruits and Veggies in Your #Diet: https://t.co/wJ9x39147k #health https://t.co/EWktCmct2J
RT @BCMHouston_News: Certain nail products can cause allergic reactions or irritations. @bcmhouston's Dr. Katta shares what to look out for…
RT @RiceAthletics: To celebrate #WorldEmojiDay, check out our favorite mascot @SammyTheOwl! 🦉👐 https://t.co/ebIKcsu2Z9